Deutsches Konsortium für Translationale Krebsforschung (DKTK)

Research facility

Location: Heidelberg, Essen/Düsseldorf, Berlin, München, Germany (DE)

ISNI: 0000000404920584

ROR: https://ror.org/04cdgtt98

Show on Map:

Publications

(15)

Relevance of tumour-infiltrating lymphocytes, PD-1 and PD-L1 in patients with high-risk, nodal-metastasised breast cancer of the German Adjuvant Intergroup Node–positive study (2019) Noske A, Möbus V, Weber K, Schmatloch S, Weichert W, Köhne CH, Solbach C, et al. Journal article Enabling wireless network support for gain scheduled control (2019) Gallenmüller S, Glebke R, Günther S, Hauser E, Leclaire M, Reif S, Rüth J, et al. Conference contribution Mutational diversity and therapy response in breast cancer: A sequencing analysis in the neoadjuvant geparsepto trial (2019) Loibl S, Treue D, Budczies J, Weber K, Stenzinger A, Schmitt WD, Weichert W, et al. Journal article Challenges of order reduction techniques for problems involving polymorphic uncertainty (2019) Pivovarov D, Willner K, Steinmann P, Brumme S, Müller M, Srisupattarawanit T, Ostermeyer GP, et al. Journal article CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG) (2016) Balermpas P, Roedel F, Roedel C, Krause M, Linge A, Lohaus F, Baumann M, et al. Journal article

‹ 1 2 ›